Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Surgery (London, England)|March 31, 2023
Development and validation of prognostic model based on extragastric lymph nodes metastasis and lymph node ratio in node-positive gastric cancer: a retrospective cohort study based on a multicenter databaseYi Zeng, Fenglin Cai, Pengliang Wang, et al.
Acta Chirurgica Belgica|May 2, 2024
Comparison of short‑term outcomes and 3-year overall survival between robotic and laparoscopic gastrectomy for gastric cancer: a propensity score matching analysisLi Zhang, Jingli Cui, Mingzhi Cai, et al.
Gastrointestinal Endoscopy|May 1, 2024
Establishment and validation of a risk score model based on EUS: assessment of lymph node metastasis in early gastric cancerSiya Liu, Mengmeng Zhang, Yang Yang, et al.
Clinical Epigenetics|January 17, 2023
Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cellsBin Li, Baoqing Ren, Gang Ma, et al.
Nature Communications|November 16, 2021
Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancerJing Guo, Aman Xu, Xiaowei Sun, et al.
JAMA Surgery|March 28, 2019
Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical TrialJing Guo, Aman Xu, Xiaowei Sun, et al.
British Journal of Cancer|June 17, 2026
LAMB3 drives gastric cancer progression through SAMD4A-mediated degradation of PHLPP2 mRNA leading to sustained PI3K-Akt activationJiamei Guo, Fenglin Cai, Mengmeng Zhang, et al.
Annals of Medicine|July 17, 2026
Intramuscular patient-derived xenografts achieve high engraftment rates in gastric cancer: implications for pharmacodynamic testing and genomic biomarker discoveryBin Li, Baogui Wang, Hang Song, et al.
Frontiers in Oncology|July 26, 2021
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical StudyYan Xu, Rupeng Zhang, Chunfeng Li, et al.
Surgery|May 15, 2025
Risk assessment of lymph node metastasis in early gastric cancer patients with vagus nerve-preserving gastrectomy: A multiple centers potential analysis in ChinaXinyu Wang, Xiangyu Wang, Qi You, et al.
Pageof 9